Determination of Phenolic Metabolites of Polycyclic Aromatic Hydrocarbons in Human Urine as Their Pentafluorobenzyl Ether Derivatives Using Liquid Chromatography−Tandem Mass Spectrometry
Authors:
- 9 December 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 79 (2) , 587-598
Abstract
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental contaminants, and a number of them are carcinogenic. One approach for measuring exposure to them is to determine the concentrations of metabolites in urine. The pyrene metabolite 1-hydroxypyrene has been used as a biomarker for exposure in numerous studies. However, determination of exposure to several PAHs may be advantageous, since the relative amounts may vary depending upon the exposure source. We developed a liquid chromatography−tandem mass spectrometry method for the determination of phenolic metabolites of naphthalene, fluorene, phenanthrene, and pyrene in human urine. Following enzymatic cleavage of the glucuronide and sulfate conjugates, the phenolic metabolites are extracted from urine and converted to pentafluorobenzyl ethers. These derivatives greatly enhance the sensitivity of detection by atmospheric pressure chemical ionization in the negative ion mode. Lower limits of quantitation range from 0.01 to 0.5 ng/mL. Stable isotope-labeled internal standards were synthesized or obtained commercially. Data on urinary excretion of several PAH metabolites in urine of smokers and nonsmokers are presented.Keywords
This publication has 25 references indexed in Scilit:
- Reference range levels of polycyclic aromatic hydrocarbons in the US population by measurement of urinary monohydroxy metabolitesEnvironmental Research, 2006
- Comparison between external and internal standard calibration in the validation of an analytical method for 1‐hydroxypyrene in human urine by high‐performance liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2006
- Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicologyClinical Biochemistry, 2005
- A study of ion suppression effects in electrospray ionization from mobile phase additives and solid‐phase extractsRapid Communications in Mass Spectrometry, 2003
- Ionization enhancement in atmospheric pressure chemical ionization and suppression in electrospray ionization between target drugs and stable‐isotope‐labeled internal standards in quantitative liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2003
- Biomonitoring of polycyclic aromatic compounds in the urine of mining workers occupationally exposed to diesel exhaustInternational Journal of Hygiene and Environmental Health, 2002
- State-of-the-art in liquid chromatography–mass spectrometryJournal of Chromatography A, 1999
- Profile of urinary phenanthrene metabolites in smokers and non-smokersBiomarkers, 1999
- A rapid and simple method for the analysis of 1-hydroxypyrene glucuronide: a potential biomarker for poly cyclic aromatic hydrocarbon exposureCarcinogenesis, 1995
- The friedel–crafts acetylation of phenanthreneJournal of the Chemical Society C: Organic, 1967